Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Dow Jumps 250 Points; Crude Oil Rises Over 1%
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday.
Akari Therapeutics Announced 15M ADS Registered Direct Offering Priced @$0.85/ADS
Akari Therapeutics, Plc (Nasdaq: AKTX) today announced it has entered into definitive agreements with healthcare-focused institutional investors alongside participation from certain existing investors, including the Akari Executive Chairman of the Board of Directors, Dr.
Akari Therapeutics To Reallocate Cash And Resources To Phase 3 Trial On Nomacopan In HSCT-TMA And To Pre-Clinical Program Of PAS-Nomacopan In GA; Will Discontinue Clinical Program Evaluating Nomacopan In Bullous Pemphigoid, Says Is Not Reducing Headcou…
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that it is prioritizing two pipeline programs. Cash and
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).
